Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy
PSP
1 other identifier
interventional
281
1 country
1
Brief Summary
Background International guidelines underline the importance of strengthening the coordination and continuity of cancer care. The different roles of general practitioners and oncologists with regard to treatment, follow-up and rehabilitation during and after cancer treatment are often obscure to cancer patients. Parallel courses of healthcare are often taking place instead of coordinated care characterized by continuity and partnership between care providers. Patients may feel uncertain about the health professionals' skills and area of responsibility. Healthcare seeking and support during and after cancer treatment may, therefore, be inappropriate, leaving patients feeling insecure and lost between care providers.The study aims to design and evaluate a new way of communication and shared decision-making that brings the patient, the oncologist and general practitioner together in a shared video-consultation in the early phase of chemotherapeutic treatment. The effect of the intervention in addition to usual care will be tested in a randomized controlled trial at Vejle Hospital in the Region of Southern Denmark. Based on sample size calculation, investigators intent to include 300 patients at the Department of Oncology and their general practitioners. Results and process outcomes will be evaluated qualitatively and quantitatively, questionnaires to patients, general practitioners and oncologists, and data from registers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started May 2016
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2016
CompletedFirst Posted
Study publicly available on registry
March 23, 2016
CompletedStudy Start
First participant enrolled
May 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedOctober 20, 2020
October 1, 2020
4.3 years
March 3, 2016
October 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Shared Care questionnaire
Patient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist.
7 month after inclusion
Secondary Outcomes (9)
Illness Intrusiveness Rating Scale (IIRS)
4 and 7 month after inclusion
European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire - Core 30 (EORTC QLQ C30)
4 and 7 month after inclusion
European Organisation for Research and Treatment of Cancer - Quality of Life- information questionnaire (EORTC QLQ INFO25)
4 and 7 month after inclusion
Generalised Anxiety Disorder Assessment (GAD-7)
4 and 7 month after inclusion
Patient Health Questionnaire (PHQ-9)
4 and 7 month after inclusion
- +4 more secondary outcomes
Study Arms (2)
Video consultation
EXPERIMENTALVideo consultation between cancer patient, general practitioner and oncologist at the start of chemotherapy treatment
usual care
NO INTERVENTIONUsual care. The patients General Practitioner will receive standard discharge summary and ambulant notes from the oncologist specialist
Interventions
At the start of the patients chemotherapy treatment a shared video consultation between the patient, general practitioner and oncologist will bee arranged. The video consultation should address distribution of roles, comorbidity, medicine, depression and anxiety symptoms, relatives and social resources.
Eligibility Criteria
You may qualify if:
- Newly referred cancer patient scheduled for chemotherapy at the Department for Oncology, Vejle Hospital, Region of Southern Denmark
- Aged 18 years and over
- Able to speak and read Danish
- Mentally able to cooperate
- Listed with a general practitioner (98 % of the danish population)
- Written and verbal informed consent given
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- National Research Center of Cancer Rehabilitationcollaborator
- Research Unit of General Practice, Odensecollaborator
- Vejle Hospitalcollaborator
- Region of Southern Denmarkcollaborator
- Odense Patient Data Explorative Networkcollaborator
Study Sites (1)
Department of Oncology, Vejle Hospital, Region of Southern Denmark
Vejle, 7100, Denmark
Related Publications (4)
Baygi F, Trabjerg TB, Jensen LH, Munch Storsveen M, Wehberg S, Sondergaard J, Gilsa Hansen D. Impact of Cross-Sectoral Video Consultation on Perceived Care Coordination and Information Satisfaction in Cancer Care: Randomized Controlled Trial. JMIR Form Res. 2025 Dec 31;9:e76910. doi: 10.2196/76910.
PMID: 41474977DERIVEDHansen DG, Trabjerg TB, Sisler JJ, Sondergaard J, Jensen LH. Cross-sectoral communication by bringing together patient with cancer, general practitioner and oncologist in a video-based consultation: a qualitative study of oncologists' and nurse specialists' perspectives. BMJ Open. 2021 May 5;11(5):e043038. doi: 10.1136/bmjopen-2020-043038.
PMID: 33952540DERIVEDTrabjerg TB, Jensen LH, Sondergaard J, Sisler JJ, Hansen DG. Cross-sectoral video consultations in cancer care: perspectives of cancer patients, oncologists and general practitioners. Support Care Cancer. 2021 Jan;29(1):107-116. doi: 10.1007/s00520-020-05467-0. Epub 2020 Apr 21.
PMID: 32318872DERIVEDTrabjerg TB, Jensen LH, Sondergaard J, Sisler JJ, Hansen DG. Improving continuity by bringing the cancer patient, general practitioner and oncologist together in a shared video-based consultation - protocol for a randomised controlled trial. BMC Fam Pract. 2019 Jun 25;20(1):86. doi: 10.1186/s12875-019-0978-8.
PMID: 31238886DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD fellow
Study Record Dates
First Submitted
March 3, 2016
First Posted
March 23, 2016
Study Start
May 1, 2016
Primary Completion
August 1, 2020
Study Completion
August 1, 2020
Last Updated
October 20, 2020
Record last verified: 2020-10